Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longya Guanxinkang Capsule in Coronary Artery Disease Angina (Qi Deficiency and Blood Stasis)
CTR20140035Phase 3Completed
- Sponsor
- Jilin Academy of Chinese Medicine Sciences
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Longya Guanxinkang in coronary arteriosclerosis, angina pectoris, sponsored by Jilin Academy of Chinese Medicine Sciences. Started Jun 2014; status: completed.
02
Drugs
Longya Guanxinkang
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20140035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140035.